Inotiv Inc. Stock
€4.04
Your prediction
Inotiv Inc. Stock
Pros and Cons of Inotiv Inc. in the next few years
Pros
Cons
Performance of Inotiv Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Inotiv Inc. | -5.880% | -28.710% | -46.098% | 4.739% | 34.756% | - | - |
| Larimar Therapeutics Inc. | -2.500% | 2.344% | -17.610% | 53.037% | 54.481% | -54.828% | - |
| Vaxart Inc. | -7.590% | -18.135% | -26.306% | 25.040% | 53.220% | -82.323% | - |
| Jaguar Health Inc. | -8.650% | 67.068% | 160.000% | 112.788% | 10.199% | -99.931% | - |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.When initially examining the financials of Inotiv, a company within the Biotechnology & Medical Research industry trading under the symbol NOTV, the figures offer a multifaceted picture. It is apparent that some traditional financial ratios are missing or report as null, which could be a sign of recent turbulence or exceptional items influencing the company's reported earnings. With a market capitalization of approximately $56.24 million, Inotiv appears to be a smaller player within its sector, which may imply both higher growth potential and higher risk for investors.
Looking at the detailed financial ratios provided, there stands a mixed bag of indicators. Let's delve into them to decipher the potential strengths and weaknesses in Inotiv's financial position.
*Pros: *
Comments
